Latest Content

Learn what angioimmunoblastic T-cell lymphoma is, how it's staged, how each stage is treated and what survivorship looks like.

Discover why walking with a partner can help cancer survivors stay safe, motivated and connected while improving physical and emotional well-being.

After reaching remission from stage 3B non-small cell lung cancer, one survivor shares the emotional journey of healing, hope and finding a new normal.

Discover how AI can help breast cancer patients understand medical terms, prepare for appointments and navigate treatment with confidence.

The FDA approved Keytruda plus Padcev before and after bladder surgery for adults with muscle-invasive bladder cancer, expanding treatment options.

The FDA approved Sarclisa Escena, a new subcutaneous treatment option for adults with multiple myeloma across newly diagnosed and relapsed settings.

ASCO 2026 findings and patient stories show how GLP-1 drugs improve metabolic health and potentially transform breast cancer survivorship.

Kristin Johnson, MSN, RN, OCN, of MD Anderson Cancer Center, combines clinical trials work with volunteer advocacy for ovarian cancer patients and survivors of human trafficking.

In a glioblastoma phase I trial, repeated brain injections of modified immune cells doubled progression-free survival to 16.1 months versus 8 months.

Before starting cell therapy, patients need more than hope — they need a plan. Dr. Muhammad Tariq breaks down what to expect at each step.

The 2026 World Cup is more than soccer—it’s a reminder of resilience, joy, and perseverance, and why small moments can lift us through life's challenges.

Join LiveLung's Charlotte meeting to learn how The White Ribbon Project is raising lung cancer awareness, reducing stigma and supporting patients.

Partnering with Lilly on a clinical trial awareness campaign, the actor reflects on his grandmother's record-setting survival and the simple message he wants every patient to hear.